Article

Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered <i>Komagataella phaffii</i>

2021-04-15

Abstract excerpt

Prevention of COVID-19 on a global scale will require the continued development of high-volume, low-cost platforms for the manufacturing of vaccines to supply on-going demand. Vaccine candidates based on recombinant protein subunits remain important because they can be manufactured at low costs in existing large-scale production facilities that use microbial hosts like Komagataella phaffii ( Pichia pastoris ). H...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cf2e70ba-22a0-5eea-a497-dd62dad7dbc4
DOI: 10.1101/2021.04.15.440035

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered <i>Komagataella phaffii</i>DOI 10.1101/2021.04.15.440035Read

Scalable Production of a <i>De Novo</i> SARS-CoV-2 Antiviral miniprotein in E <i>scherichia coli</i>Semantic proximity Read

Scale-up Production and Immunological Assessment of Recombinant SARS- CoV-2 Spike RBD in Pichia pastorisSemantic proximity Read

Yeast-based production platform for potent and stable heavy chain-only antibodiesSemantic proximity Read

A scalable cell-free manufacturing platform for two-step bioproduction of immunogenic conjugate vaccinesSemantic proximity Read

Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for VaccinesSemantic proximity Read

Process Development and Scale-up Optimization of the SARS-CoV-2 Receptor Binding Domain-Based Vaccine Candidate, RBD219-N1C1Semantic proximity Read

Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal NeedsSemantic proximity Read

Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain, RBD203-N1 as a COVID-19 Protein Vaccine CandidateSemantic proximity Read

Emerging Technologies for Low‐Cost, Rapid Vaccine ManufactureSemantic proximity Read

Design of a Multi-epitope Vaccine Against Human Glanders Targeting Outer Membrane β-barrel Proteins of <i>Burkholderia mallei</i>Semantic proximity Read

Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production.Semantic proximity Read

Understanding K. phaffii ( Pichia pastoris ) Host Cell Proteins: Proteomic Analysis and Flow-through Affinity ClearanceSemantic proximity Read